Snake Venom Components as Therapeutic Drugs in Ischemic Heart Disease.

Messadi, Erij·Biomolecules·2023·
RPEP-071782023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Snake Venom Components as Therapeutic Drugs in Ischemic Heart Disease.
Published In:
Biomolecules, 13(10) (2023)
Authors:
Messadi, Erij
Database ID:
RPEP-07178

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-07178·https://rethinkpeptides.com/research/RPEP-07178

APA

Messadi, Erij. (2023). Snake Venom Components as Therapeutic Drugs in Ischemic Heart Disease.. Biomolecules, 13(10). https://doi.org/10.3390/biom13101539

MLA

Messadi, Erij. "Snake Venom Components as Therapeutic Drugs in Ischemic Heart Disease.." Biomolecules, 2023. https://doi.org/10.3390/biom13101539

RethinkPeptides

RethinkPeptides Research Database. "Snake Venom Components as Therapeutic Drugs in Ischemic Hear..." RPEP-07178. Retrieved from https://rethinkpeptides.com/research/messadi-2023-snake-venom-components-as

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.